Vyome Holdings, Inc. (HIND)
2.18
+0.01
(+0.46%)
USD |
NASDAQ |
Sep 02, 16:00
2.20
+0.02
(+0.92%)
Pre-Market: 20:00
Vyome Holdings Cash from Operations (Annual) : -3.749M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -3.749M |
| December 31, 2024 | -0.6141M |
| December 31, 2023 | -16.96M |
| December 31, 2022 | -21.90M |
| December 31, 2021 | -15.38M |
| December 31, 2020 | -8.55M |
| Date | Value |
|---|---|
| December 31, 2019 | -22.87M |
| December 31, 2018 | -29.43M |
| December 31, 2017 | -30.62M |
| December 31, 2016 | -19.37M |
| December 31, 2015 | -11.39M |
| December 31, 2014 | -9.907M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Cardiac Biotech Solutions, Inc. | -0.6367M |
| Anika Therapeutics, Inc. | 11.19M |
| Enovis Corp. | 217.29M |
| Edwards Lifesciences Corp. | 1.595B |
| Perspective Therapeutics, Inc. | -82.48M |